loadpatents
name:-0.0097098350524902
name:-0.0042018890380859
name:-0.0013730525970459
Institut Bergonie Patent Filings

Institut Bergonie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Institut Bergonie.The latest application filed is for "use of sulconazole as a furin inhibitor".

Company Profile
1.6.8
  • Institut Bergonie - Bordeaux FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Sulconazole As A Furin Inhibitor
App 20220047556 - KHATIB; Abdel-Majid ;   et al.
2022-02-17
Compounds And Pharmaceutical Compositions For Reducing Cd95-mediated Cell Motility
App 20210238143 - VACHER; Pierre ;   et al.
2021-08-05
Methods and pharmaceutical compositions for the treatment of kidney cancer
Grant 11,052,131 - Siegfried , et al. July 6, 2
2021-07-06
Malignant Hematopoietic Cell Microcompartment And Method For Preparing Such A Microcompartment
App 20200370022 - BRESSON-BEPOLDIN; LAURENCE ;   et al.
2020-11-26
Polypeptides and uses thereof for reducing CD95-mediated cell motility
Grant 10,556,941 - Legembre , et al. Feb
2020-02-11
Methods And Pharmaceutical Compositions For The Treatment Of Kidney Cancer
App 20200030413 - SIEGFRIED; Geraldine ;   et al.
2020-01-30
Methods And Pharmaceutical Compositions For Reducing Cd95- Mediated Cell Motility
App 20190350907 - LEGEMBRE; Patrick ;   et al.
2019-11-21
Polypeptides And Uses Thereof For Reducing Cd95-mediated Cell Motility
App 20190085050 - LEGEMBRE; Patrick ;   et al.
2019-03-21
Polypeptides and uses thereof for reducing CD95-mediated cell motility
Grant 10,189,887 - Legembre , et al. Ja
2019-01-29
Prognostic molecular signature of sarcomas, and uses thereof
Grant 9,708,666 - Chibon , et al. July 18, 2
2017-07-18
Polypeptides And Uses Thereof For Reducing Cd95-mediated Cell Motility
App 20170044234 - LEGEMBRE; Patrick ;   et al.
2017-02-16
Compositions For Potentiating Apoposis Signals In Tumour Cells
App 20120034210 - Vacher; Pierre ;   et al.
2012-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed